SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-19-000019
Filing Date
2019-05-03
Accepted
2019-05-02 20:14:29
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20190331x10q.htm 10-Q 1190418
2 EX-31.1 plse-20190331xex31_1.htm EX-31.1 20371
3 EX-31.2 plse-20190331xex31_2.htm EX-31.2 20816
4 EX-32.1 plse-20190331xex32_1.htm EX-32.1 19315
  Complete submission text file 0001625101-19-000019.txt   4405753

Data Files

Seq Description Document Type Size
5 EX-101.INS plse-20190331.xml EX-101.INS 796722
6 EX-101.SCH plse-20190331.xsd EX-101.SCH 33340
7 EX-101.CAL plse-20190331_cal.xml EX-101.CAL 48431
8 EX-101.DEF plse-20190331_def.xml EX-101.DEF 127520
9 EX-101.LAB plse-20190331_lab.xml EX-101.LAB 291873
10 EX-101.PRE plse-20190331_pre.xml EX-101.PRE 258879
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 19793825
SIC: 3841 Surgical & Medical Instruments & Apparatus